Rare. Group of serious immune deficiencies that present with the combined absence of lymphocytes T and B functions. At least 12 different genetic causes have been identified:
- deficiency in the γ chain common to 6 different cytokine receptors: 45%, X-linked transmission [MIM 300 400; 308 380]
- adenosine deaminase deficiency: 15% (see this term)
- deficiency in α chain of the IL-7 receptor (ch 5): 11%
- deficiency in Janus kinase 3 (gene JAK3 on ch 19): < 10%
- deficiency in CD3 chains (11q23, 3 subtypes)
- CD45 deficiency
- RAG1 and RAG2 recombination activating gene deficiency (Ommen syndrome: see this term)
- deficiency in artemis (DICS type athabascan, DICS alymphocytic type) [MIM 602 450] ( DCLRE1C gene on 10p13): with high sensitivity to ionizing radiation
- deficiency in ligase 4
Clinical presentation: severe, early and recurrent infections: pneumonia, septicemia, meningitis, treatment-resistant fungal infections.
Diagnosis: number of lymphocytes and the proportion of lymphocytes T, B and NK: there are 4 major phenotypes (see table). Decreased lvels of all classes of immunoglogulines (IgG, IgM, IgA, IgE) when those of maternal origin have disappeared
T- B + NK + |
|
Deficiency in chain α of the IL-7 receptor |
5p13 |
Deficiency in chain δ of CD3 |
11q23 |
Deficiency in chain ε of CD3 |
11q23 |
T- B+ NK- |
|
Deficiency in chain γ common to the cytokine receptors |
Xq13.1 |
Deficiency in CD45 |
1q31-1q32 |
Deficiency in JAK3 |
19p13.1 |
T-B-NK+ |
|
Deficiency in artemis protein |
10p13 |
Deficiency in RAG1 or RAG2 |
11p13 |
T-B-NK- |
|
Deficiency in ADA |
20q13.11 |
Treatment:
- as long as a waiting list for bone marrow or stem cells transplantation: isolation, no live attenuated vaccines, transfusion of irradiated and leucoreduced blood products
- bone marrow transplantation from a HLA compatible donor
Anesthetic implications:
antibioprophylaxis and measures of strict asepsis; side effects of immunosuppression in case of hematopoietic transplantation
References :
-
Updated: March 2019